Autoantibodies to amyloid-βand Alzheimer's disease

Annals of Neurology

Volumn 49, Issue 6, 2001, Pages 808-810

  Hyman, Bradley T ^a,c   Smith, Carolyn ^a   Buldyrev, Ilya ^a   Whelan, Christa ^b   Brown, Harold ^a   Tang, Ming Xin ^a   Mayeux, Richard ^a  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AUTOANTIBODY;

AGED; AGING; ALZHEIMER DISEASE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AUTOANTIBODIES; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUPS; FEMALE; HUMANS; MALE;

EID: 0034992393     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.1061     Document Type: Article

References (6)

1. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
2. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzhelmer disease
3. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
4. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
5. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
6. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease